How to further improve M. hyo vaccine efficacy?

11-11-2016 | | |
How to further improve M. hyo vaccine efficacy? Photo: Ceva Animal Health
How to further improve M. hyo vaccine efficacy? Photo: Ceva Animal Health
Although immunity against M. hyo is not fully understood, it is a fact that vaccination helps reduce the size and duration of lung lesions. Both antigenic and adjuvant components are essential to generate immune responses. Lipopolysaccharides appear to boost both humoral and cell-mediated responses to an M. hyo vaccine. Mycoplasma hyopneumoniae (M. hyo) is a primary pathogen causing Enzootic Pneumonia (EP), one of the most prevalent respiratory diseases in pigs. It is also one of the main pa


Get full access to all stories on Pig Progress

This Premium article is exclusively available for subscribers

Obtain insights from exclusive interviews

Dive into articles covering trending industry topics

Get a glimpse into pig farms worldwide

All the news is brought to you by experienced editors and experts from around the world

Redacteur 1

Vincent
ter Beek

Redacteur 2

Kees van
Dooren

Redacteur 3

Treena
Hein

Krejci